IDENTIFY NEW FUNDING

Opportunities

Oncology Drug Funding

2013

This Report is only Available on request...​

RELEASED - April 2013

Download Flyer1.1 MB
Download TOC1.2 MB
Free Download Reuest

321

Oncology Focused Investors

Oncology Drug Funding 2013 is first of its kind funding intelligence report, which provides complete landscape on cancer drug funding starting from early, mid to late stage funding and offers quick navigation on past 10 years major investments in the domain.

First Report to Cover all Aspects of Cancer Drug Funding Intelligence

largest coverage

providing intelligence at fingertips

1
Investors

Active Venture Capital Firm Profiles

1
Companies

Oncology Company Funding Details

1
Venture Partners

Venture Partners Professional Details

1 +
Funding Round Covered

Funding Round / Series Details